Industrials [ 5/12 ] | Machinery [ 12/74 ]
NYSE | Common Stock
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan.
It operates through two segments, Medical and Technologies.
The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products.
This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation.
The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools.
The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services.
It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs.
The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006.
The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 1, 24 | 0.10 Increased by +25.00% | 0.08 Increased by +25.00% |
| Apr 30, 24 | 0.06 Increased by 0.00% | 0.06 |
| Feb 13, 24 | 0.15 Increased by +36.36% | 0.14 Increased by +7.14% |
| Nov 1, 23 | 0.05 Increased by +66.67% | 0.05 |
| Aug 2, 23 | 0.08 Decreased by -38.46% | 0.06 Increased by +33.33% |
| May 3, 23 | 0.06 Decreased by -40.00% | 0.05 Increased by +20.00% |
| Feb 14, 23 | 0.11 Increased by +191.67% | 0.12 Decreased by -8.33% |
| Nov 1, 22 | 0.03 Increased by +100.43% | 0.06 Decreased by -50.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 206.80 M Increased by +8.16% | -13.60 M Decreased by -12.40% | Decreased by -6.58% Decreased by -3.92% |
| Jun 30, 24 | 207.10 M Increased by +5.02% | -11.70 M Increased by +57.76% | Decreased by -5.65% Increased by +59.78% |
| Mar 31, 24 | 192.60 M Increased by +5.77% | -25.80 M Increased by +42.79% | Decreased by -13.40% Increased by +45.91% |
| Dec 31, 23 | 230.40 M Increased by +5.74% | -15.20 M Increased by +90.68% | Decreased by -6.60% Increased by +91.19% |
| Sep 30, 23 | 191.20 M Increased by +18.83% | -12.10 M Increased by +79.97% | Decreased by -6.33% Increased by +83.14% |
| Jun 30, 23 | 197.20 M Increased by +12.17% | -27.70 M Increased by +52.73% | Decreased by -14.05% Increased by +57.86% |
| Mar 31, 23 | 182.10 M Increased by +11.58% | -45.10 M Decreased by -65.81% | Decreased by -24.77% Decreased by -48.60% |
| Dec 31, 22 | 217.90 M Increased by +141.49 M% | -163.10 M Decreased by -15.73 M% | Decreased by -74.85% Increased by +88.88% |